Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 4 offerings, 6 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-412486 | Sep 7, 2021 EDGAR ↗ | Sep 7, 2021 D EDGAR ↗ | 0 | $100,000,000 | $94,749,964 | Other Health Care |
| 021-367213 | May 18, 2020 EDGAR ↗ | Oct 13, 2020 D/A EDGAR ↗ | 2 latest Oct 13, 2020 | $44,330,291 | $44,330,291 | Other Health Care |
| 021-203985 | Oct 4, 2013 EDGAR ↗ | Oct 4, 2013 D EDGAR ↗ | 0 | $3,602,959 | $3,149,998 | Other |
| 021-197903 | Jun 13, 2013 EDGAR ↗ | Jun 13, 2013 D EDGAR ↗ | 0 | $4,578,471 | $3,023,470 | Other Technology |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Sep 7, 2021 D Other Health Care — $94,749,964 sold of $100,000,000 · 20 investors EDGAR ↗
| Filing | Form D filed Sep 7, 2021SEC file no. 021-412486 · accession 0001579188-21-000001 |
|---|
| Raise progress | $94,749,964 sold of $100,000,000 offered (95%) · $5,250,036 remaining · first sale Aug 23, 2021 |
|---|
| Filing timing | Date of first sale: Aug 23, 2021 · Form D filed: Sep 7, 2021 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 1,888 days (5.2 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 20 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Julia Hu, President and CEO (Sep 7, 2021) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $100,000,000. Typical range: $829,831–$9,999,998.
Investors: 20. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Oct 13, 2020 D/A Other Health Care — $44,330,291 sold of $44,330,291 · 58 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Oct 13, 2020 · amends 0001579188-20-000003 ↗SEC file no. 021-367213 · accession 0001579188-20-000004 · filing 3 of 3 in this offering |
|---|
| Raise progress | $44,330,291 sold of $44,330,291 offered (100%) · $0 remaining · first sale May 1, 2020 |
|---|
| Filing timing | Date of first sale: May 1, 2020 · Original Form D filed: May 18, 2020 (17 days after first sale) · This amendment (Form D/A) filed: Oct 13, 2020 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,367 days (6.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Oct 13, 2020. Most recent amendment for this offering in our index: this filing, Oct 13, 2020. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 58 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Julia Hu, President and Chief Executive Officer (Oct 13, 2020) |
|---|
| Changes vs previous filing | - total sold: $39,330,326 (Sep 22, 2020) → $44,330,291 (Oct 13, 2020)
- total offering: $40,000,000 (Sep 22, 2020) → $44,330,291 (Oct 13, 2020)
- remaining: $669,674 (Sep 22, 2020) → $0 (Oct 13, 2020)
- investors: 53 (Sep 22, 2020) → 58 (Oct 13, 2020)
Compared with the D/A filed Sep 22, 2020 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $25,000–$100,000.
Offering size: $44,330,291. Typical range: $1,500,000–$10,000,000.
Investors: 58. Typical range: 1–11."Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Sep 22, 2020 D/A Other Health Care — $39,330,326 sold of $40,000,000 · 53 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Sep 22, 2020 · amends 0001579188-20-000002 ↗SEC file no. 021-367213 · accession 0001579188-20-000003 · filing 2 of 3 in this offering |
|---|
| Raise progress | $39,330,326 sold of $40,000,000 offered (98%) · $669,674 remaining · first sale May 1, 2020 |
|---|
| Filing timing | Date of first sale: May 1, 2020 · Original Form D filed: May 18, 2020 (17 days after first sale) · This amendment (Form D/A) filed: Sep 22, 2020 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,367 days (6.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated Sep 22, 2020. Most recent amendment for this offering in our index: Oct 13, 2020 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 53 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Julia Hu, President and Chief Executive Officer (Sep 22, 2020) |
|---|
| Changes vs previous filing | - total sold: $16,997,951 (May 18, 2020) → $39,330,326 (Sep 22, 2020)
- remaining: $23,002,049 (May 18, 2020) → $669,674 (Sep 22, 2020)
- investors: 37 (May 18, 2020) → 53 (Sep 22, 2020)
Compared with the D filed May 18, 2020 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $25,000–$100,000.
Offering size: $40,000,000. Typical range: $1,500,000–$10,000,000.
Investors: 53. Typical range: 1–11."Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
May 18, 2020 D Other Health Care — $16,997,951 sold of $40,000,000 · 37 investors EDGAR ↗
| Filing | Form D filed May 18, 2020SEC file no. 021-367213 · accession 0001579188-20-000002 · filing 1 of 3 in this offering |
|---|
| Raise progress | $16,997,951 sold of $40,000,000 offered (42%) · $23,002,049 remaining · first sale May 1, 2020 |
|---|
| Filing timing | Date of first sale: May 1, 2020 · Form D filed: May 18, 2020 (17 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,367 days (6.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Oct 13, 2020 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 37 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(c) — general advertising allowed; all investors must be verified accredited |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Julia Hu, President and Chief Executive Officer (May 18, 2020) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $25,000–$100,000.
Offering size: $40,000,000. Typical range: $1,500,000–$10,000,000.
Investors: 37. Typical range: 1–11."Similar" = Other Health Care, Rule 506(c). Based on 171 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(c); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 141, offering size 158, investors 116. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Oct 4, 2013 D Other — $3,149,998 sold of $3,602,959 · 6 investors EDGAR ↗
| Filing | Form D filed Oct 4, 2013SEC file no. 021-203985 · accession 0001579188-13-000002 |
|---|
| Raise progress | $3,149,998 sold of $3,602,959 offered (87%) · $452,961 remaining · first sale Sep 27, 2013 |
|---|
| Filing timing | Date of first sale: Sep 27, 2013 · Form D filed: Oct 4, 2013 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,775 days (13.1 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 6 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | President, President and CEO (Oct 3, 2013) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $5,000–$50,000.
Offering size: $3,602,959. Typical range: $500,000–$7,000,000.
Investors: 6. Typical range: 2–14."Similar" = industry reported as "Other", Rule 506(b). Based on 18,678 Form D filings 2021–2026 in the same industry and exemption (Other, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 6,590, offering size 16,855, investors 16,531. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jun 13, 2013 D Other Technology — $3,023,470 sold of $4,578,471 · 22 investors EDGAR ↗
| Filing | Form D filed Jun 13, 2013SEC file no. 021-197903 · accession 0001579188-13-000001 |
|---|
| Raise progress | $3,023,470 sold of $4,578,471 offered (66%) · $1,555,001 remaining · first sale Apr 13, 2013 Issuer's note: Aggregate value of $2,999,999.98 of Series A-1 Preferred Stock was offered, of which $1,444,998.73 was issued and sold. Aggregate value of $1,578,472.04 in notes (w/interest) was converted into Series A Preferred Stock (or 1,186,809 shares). |
|---|
| Filing timing | Date of first sale: Apr 13, 2013 · Form D filed: Jun 13, 2013 (61 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,942 days (13.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 22 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Technology |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | Julia Hu, President (Jun 11, 2013) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Amendment history — 2 amendments on this page, each compared with the filing before it in the same offering
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|
| Oct 13, 2020 EDGAR ↗ | 021-367213 | Sep 22, 2020 D/A | total sold: $39,330,326 (Sep 22, 2020) → $44,330,291 (Oct 13, 2020) · total offering: $40,000,000 (Sep 22, 2020) → $44,330,291 (Oct 13, 2020) · remaining: $669,674 (Sep 22, 2020) → $0 (Oct 13, 2020) · and 1 more (open the filing above) |
| Sep 22, 2020 EDGAR ↗ | 021-367213 | May 18, 2020 D | total sold: $16,997,951 (May 18, 2020) → $39,330,326 (Sep 22, 2020) · remaining: $23,002,049 (May 18, 2020) → $669,674 (Sep 22, 2020) · investors: 37 (May 18, 2020) → 53 (Sep 22, 2020) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Sep 7, 2021. Industry as reported, by offering: Previous offerings: Other Technology (2013), Other (2013). Latest offering: Other Health Care (2020–2021; most recent Sep 7, 2021).
Key people 5
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| JH Julia Hu | Executive Officer, Director | CA | Jun 13, 2013 → Sep 7, 2021 on 6 of 6 filings listed on the latest filing | — |
| DF David Fiore | Executive Officer | CA | Jun 13, 2013 → Oct 4, 2013 on 2 of 6 filings not listed on the latest filing (Sep 7, 2021) | 1 other issuer |
| DF David Fleshman | Director | CA | Oct 4, 2013 on 1 of 6 filings not listed on the latest filing (Sep 7, 2021) | 6 other issuers |
| AU Anis Uzzaman | Director | CA | Oct 4, 2013 on 1 of 6 filings not listed on the latest filing (Sep 7, 2021) | 19 other issuers |
| WD Weili Dai | Director | CA | Oct 4, 2013 on 1 of 6 filings not listed on the latest filing (Sep 7, 2021) | 4 other issuers |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Connections
Other issuers listing the same people:
- Astrana Health, Inc. — Weili Dai · latest filing Nov 21, 2025
- Wolley, Inc. — Weili Dai · latest filing Nov 6, 2025
- CapsoVision, Inc — Weili Dai · latest filing Jul 23, 2024
- Fenox Venture Co. III, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Fenox Venture Co. XVII, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Fenox Venture Co. XVIII, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Fenox Venture Co. XXVI, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures Co. VIII, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures Co. XI, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures Co. XIV, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures Co. XVIII, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures Co., IV, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures SPV I, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures SPV II, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures SPV IV, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Pegasus Tech Ventures SPV VI, L.P. — Md Anis Uzzaman · latest filing May 24, 2024
- Fenox Venture Co. IX, L.P. — Md Anis Uzzaman · latest filing May 23, 2024
- Fenox Venture Co. VIII, L.P. — Md Anis Uzzaman · latest filing May 23, 2024
- Fenox Venture Co. XI, L.P. — Md Anis Uzzaman · latest filing May 23, 2024
- Fenox Innotech Venture Co. VI, L.P. — Md Anis Uzzaman · latest filing May 22, 2024
- Fenox Venture Co. IV, L.P. — Md Anis Uzzaman · latest filing May 22, 2024
- Asset Management Ventures V, L.P. — David Fleshman · latest filing Nov 19, 2021
- SANO INTELLIGENCE, INC. — Md Anis Uzzaman · latest filing Jan 12, 2018
- Evidation Health, Inc. — David Fleshman · latest filing Apr 26, 2017
- Asset Management Ventures IV, L.P. — David Fleshman · latest filing Apr 5, 2016
- Gen9, Inc. — Weili Dai · latest filing Jul 30, 2014
- Asset Management Ventures Fund, L.P. — David Fleshman · latest filing Apr 23, 2012
- Provade, Inc — David Fleshman · latest filing Aug 10, 2010
- Servo Software Inc — David Fleshman · latest filing Apr 15, 2010
- Loomia Inc — David Fiore · latest filing Sep 30, 2009
Shared address: this business address appears on filings for 5 other issuers. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Lark Technologies, Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for Lark Technologies, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in Lark Technologies, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #182,496 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for CA yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.